Chavez Ryan Daniel 4
4 · Asterias Biotherapeutics, Inc. · Filed Mar 19, 2018
Insider Transaction Report
Form 4
Chavez Ryan Daniel
Exec. VP of Fin & Gen. Counsel
Transactions
- Award
Common Stock
2018-03-15+68,708→ 203,273 total - Tax Payment
Common Stock
2018-03-15$1.95/sh−21,633$42,184→ 181,640 total - Award
Common Stock (restricted stock units)
2018-03-15+50,000→ 134,565 total - Award
Stock Options
2018-03-15+150,000→ 150,000 totalExercise: $1.95Exp: 2028-03-14→ Common Stock (150,000 underlying)
Holdings
- 380,000
Stock Option
Exercise: $2.91Exp: 2026-07-17→ Common Stock (380,000 underlying)
Footnotes (3)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the grant of 68,708 shares of restricted stock, which is reported herewith on this Form 4.
- [F2]Subject to Mr. Chavez's continued employment with the Company, 25% of the granted stock options vest on the first anniversary of the grant date, and the remaining 75% of the stock options in equal monthly installments over 36 months commencing after the first anniversary of the grant date. The grant date of these options was March 14, 2018. The stock options are exercisable upon vesting.
- [F3]Subject to Mr. Chavez's continued employment with the Company, 25% of the granted stock options vest on the first anniversary of the grant date, and the remaining 75% of the stock options in equal monthly installments over 36 months commencing after the first anniversary of the grant date. The grant date of these options was July 18, 2016. The stock options are exercisable upon vesting.